Check-Cap Ltd. (CHEK) is a late-clinical stage company redefining the screening of colorectal cancer via the introduction of C-Scan. It is the pioneer screening test for
Check-Cap Ltd. (CHEK) stock prices were down by 19.5364% some time after market trading commenced on June 30th, 2021, bringing the price per share down
Bionano Genomics Inc. (BNGO) stock soared 55.84% to $4.8 in the pre-market trading. The company recently granted 180-day extension by Nasdaq to regain compliance with
Ocugen Inc. (OCGN) stock plunged -8.85% to $2.37 in the pre-market trading after reporting the appointment of a vaccine scientific advisory board comprised of leading
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.